These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6183928)

  • 41. [Pharmacokinetics and preliminary evaluation of the anti-arrhythmic effectiveness of N-acetylprocainamide in ventricular disorders of cardiac rhythm].
    Ochotny R; Lowicki Z
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1445-7. PubMed ID: 2421273
    [No Abstract]   [Full Text] [Related]  

  • 42. Ventricular ectopy.
    Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
    J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
    [No Abstract]   [Full Text] [Related]  

  • 43. The neurobiologically active benzamides and related compounds: some historical aspects.
    Angrist BM
    Adv Biochem Psychopharmacol; 1982; 35():1-6. PubMed ID: 6756058
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
    Matusewicz W; Orszulak DE
    Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical trials of benzamides in psychiatry.
    Peselow ED; Stanley M
    Adv Biochem Psychopharmacol; 1982; 35():163-94. PubMed ID: 6756060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
    Witkowska M
    Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides.
    Kohli JD; Glock D; Goldberg LI
    Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064
    [No Abstract]   [Full Text] [Related]  

  • 48. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.
    Pani L; Gessa GL
    Mol Psychiatry; 2002; 7(3):247-53. PubMed ID: 11920152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of cardiovascular drugs.
    Vlietstra RE
    Cardiovasc Clin; 1980; 10(3):255-70. PubMed ID: 6991113
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
    Meltzer HY; So R; Fang VS
    Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
    [No Abstract]   [Full Text] [Related]  

  • 51. The substituted benzamides in gastroenterology.
    Nowak TV; Schulze-Delrieu K
    Adv Biochem Psychopharmacol; 1982; 35():195-203. PubMed ID: 6756061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease states and drug pharmacokinetics.
    Koup JR
    J Clin Pharmacol; 1989 Aug; 29(8):674-9. PubMed ID: 2674207
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics and metabolism of the benzamides.
    Bateman DN
    Adv Biochem Psychopharmacol; 1982; 35():143-62. PubMed ID: 6183928
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.